INARI MED INC's ticker is NARI and the CUSIP is 45332Y109. A total of 250 filers reported holding INARI MED INC in Q2 2023. The put-call ratio across all filers is 0.23 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $203,002 | +23.3% | 3,104 | +9.6% | 0.01% | +37.5% |
| Q2 2023 | $164,594 | +3.2% | 2,831 | +9.6% | 0.01% | 0.0% |
| Q1 2023 | $159,536 | -15.8% | 2,584 | -13.3% | 0.01% | 0.0% |
| Q4 2022 | $189,472 | -10.4% | 2,981 | +2.4% | 0.01% | -20.0% |
| Q3 2022 | $211,455 | +6.8% | 2,911 | 0.0% | 0.01% | +11.1% |
| Q2 2022 | $197,919 | -1.3% | 2,911 | +31.6% | 0.01% | +28.6% |
| Q1 2022 | $200,496 | -75.1% | 2,212 | -74.9% | 0.01% | -36.4% |
| Q4 2021 | $804,636 | +6.0% | 8,816 | -5.8% | 0.01% | 0.0% |
| Q3 2021 | $759,015 | -13.0% | 9,359 | +0.1% | 0.01% | -8.3% |
| Q2 2021 | $872,541 | +76.3% | 9,354 | +102.2% | 0.01% | +71.4% |
| Q1 2021 | $494,875 | +142.4% | 4,625 | +97.7% | 0.01% | +133.3% |
| Q4 2020 | $204,171 | +26.5% | 2,339 | 0.0% | 0.00% | 0.0% |
| Q3 2020 | $161,438 | – | 2,339 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Affinity Asset Advisors, LLC | 125,000 | $11,409,000 | 4.14% |
| SECTORAL ASSET MANAGEMENT INC | 163,550 | $14,927,000 | 2.25% |
| Lisanti Capital Growth, LLC | 81,460 | $7,435,000 | 1.08% |
| Pier Capital, LLC | 99,422 | $9,074,000 | 0.96% |
| Beck Bode, LLC | 33,384 | $3,047,000 | 0.76% |
| Nicholas Investment Partners, LP | 104,932 | $9,577,000 | 0.61% |
| CNA FINANCIAL CORP | 24,773 | $2,261,000 | 0.59% |
| NEXT CENTURY GROWTH INVESTORS LLC | 56,523 | $5,158,000 | 0.46% |
| HARBOURVEST PARTNERS LLC | 38,540 | $3,518,000 | 0.45% |
| Birchview Capital, LP | 7,000 | $639,000 | 0.41% |